Patent · US Active

Antibodies against glucagon receptor and their use

US9102732B2 · kind B2 · utility

8Cited by
0References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 8, 2009
Grant dateAug 11, 2015
Priority date—
Expiry dateSep 12, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/76
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed are immunological compositions and methods for reducing activity of glucagon signaling using antibodies against glucagon receptor.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.